Pamplona, Spain – May 11st, 2026 – Palobiofarma S.L., a biopharmaceutical company focused on the discovery and development of innovative treatments for orphan diseases, today announced significant progress in the clinical development of PBF‑999, its novel PDE10 inhibitor for the treatment of...